SQUAWK/NEWS
Menu
Live News EARNINGS H impact

Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2K

As of the date of this press release, combined with 72,733 ADSs purchased in the last two post-earnings trading windows, Mr. Han has purchased an aggregate of 145,874 of the Company’s ADSs for US$1,976,542.90 across three consecutive post-earnings trading windows, indicating his confidence in the Company’s business and prospect. Mr. Han may continue to purchase the Company’s ADSs through open-market transactions, privately negotiated transactions or block trades, or other legally permissible means, depending on market conditions and in accordance with the applicable rules and regulations. The timing and conditions of Mr. Han’s purchase will be subject to various factors, including the requirements under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as well as the Company’s insider trading policy.

BNR

As of the date of this press release, combined with 72,733 ADSs purchased in the last two post-earnings trading windows, Mr.

Han has purchased an aggregate of 145,874 of the Company’s ADSs for US$1,976,542.90 across three consecutive post-earnings trading windows, indicating his confidence in the Company’s business and prospect.

Mr.

Han may continue to purchase the Company’s ADSs through open-market transactions, privately negotiated transactions or block trades, or other legally permissible means, depending on market conditions and in accordance with the applicable rules and regulations.

The timing and conditions of Mr.

Han’s purchase will be subject to various factors, including the requirements under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as well as the Company’s insider trading policy.